RankingsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Total current assets

RaQualia Pharma Inc.【JP:4579】

Market cap
¥22.3B
P/E ratio
-313.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Dec 31, 20244,539-8.43%
Dec 31, 20234,957+2.80%
Dec 31, 20224,822+20.44%
Dec 31, 20214,004+41.26%
Dec 31, 20202,834-7.59%
Dec 31, 20193,067+56.31%
Dec 31, 20181,962-40.94%
Dec 31, 20173,322+83.91%
Dec 31, 20161,806-33.29%
Dec 31, 20152,708-16.97%
Dec 31, 20143,261

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)